Cns Therapy Development for Lysosomal Storage Disorders

The summary for the Cns Therapy Development for Lysosomal Storage Disorders grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Cns Therapy Development for Lysosomal Storage Disorders: The goal of this Program Announcement is to solicit applications on lysosomal storage disorders (LSDs) focused on improving CNS treatment outcomes, enhancing the effectiveness of delivery and targeting of cells, enzymes, drugs and genes into the brain, and developing novel therapeutic modalities, such as implantable biocapsules and micro-electro-mechanical systems (MEMS)-based devices. Lysosomal storage disorders constitute a group of recessive genetic diseases resulting from cellular enzymatic deficiencies of acid hydrolases that normally catalyze the metabolism of glycoproteins, glycolipids and other macromolecules, or from defects in transporter proteins leading to pathogenic accumulation of these substances in lysosomes. Treatment modalities for LSDs are currently limited to bone marrow transplantation (BMT) and enzyme replacement therapy (ERT). These approaches while providing significant promise for treatment of the visceral manifestations of LSDs, do little to address CNS pathologies for this group of disorders. Thus this announcement specifically encourages the transition from basic studies in LSDs to translational research for improved delivery of therapeutic cells, proteins, genes, and small molecules across the blood-brain barrier.
Federal Grant Title: Cns Therapy Development for Lysosomal Storage Disorders
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAS-04-120
Type of Funding: Grant
CFDA Numbers: 93.853
CFDA Descriptions: Extramural Research Programs in the Neurosciences and Neurological Disorders
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Jul 06, 2004
Creation Date: Dec 18, 2006
Archive Date: Feb 03, 2007
Total Program Funding:
Maximum Federal Grant Award: $200,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) State governments Public and State controlled institutions of higher education Small businesses Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments Special district governments For profit organizations other than small businesses Independent school districts City or township governments Private institutions of higher education
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants
Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Ge...
Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...
Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...
Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contribution...
Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging fin...
NINDS Cooperative Small Business Awards In Translational Research (SBIR/U44)
NINDS Institutional Center Core Grants to Support Neuroscience Research
Career Development Award to Promote Diversity in Neuroscience Research
More Grants from the National Institutes of Health
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Olde...
NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies w...
Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental S...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com